Importance: Quality of vision after multifocal intraocular lens (IOLs) implantation in relation to patient satisfaction. It is important to include the evaluation of visual quality and patient satisfaction in clinical practice.
INTRODUCTION
One of the critical issues of multifocal IOLs is the quality of vision achieved after their implantation which is directly related to the level of patient satisfaction. 1 Visual disturbances such as halos or glare have been reported following implantation of multifocal IOLs. [1] [2] [3] [4] The frequency and intensity of these undesired visual disturbances, despite the correction of the refractive error, may condition final patient satisfaction and consequently the impact of the surgery on patient quality of life. 5, 6 For this reason, clinical comparative studies evaluating different types of multifocal IOLs should also include in their examination protocols tests for evaluating the visual quality, patient satisfaction and the impact on patient quality of life. The aim of the current study was to evaluate and compare, at different time points and up to 12 months postoperatively, contrast sensitivity, spectacle independence and patient satisfaction outcomes, as well as the incidence of postoperative visual disturbances degrading the visual quality following implantation of a bifocal diffractive-refractive or a trifocal diffractiverefractive or an apodized-diffractive bifocal IOL.
METHODS

Patients
A total of 104 eyes of 52 patients were enrolled in this prospective comparative randomized multicentre clinical trial. Three different ophthalmological centres were involved in the recruitment of patients. All patients underwent uneventful phacoemulsification surgery with bilateral implantation of one of three multifocal IOLs assigned randomly (randomization number allocated to the patient according to chronological order of the surgery). According to this random assignment, three groups were differentiated: AT LISA group in which the bifocal diffractiverefractive IOL AT LISA 809 M (Carl Zeiss Meditec, Jena, Germany) was implanted, AT LISA tri group in which the trifocal IOL AT LISAtri 839MP (Carl Zeiss Meditec) was implanted, and ReSTOR group in which the apodized bifocal IOL ReSTOR SN6AD1 (Alcon, Fort Worth, TX, United States) was implanted. All patients were unaware of the implanted lens type and an independent observer with good clinical practice certified performed the postoperative measurements in each centre.
All patients (aged 50 to 80 years) included in the study had cataract, sought spectacle independence and had a pre-existing corneal astigmatism of less than 1.00 D. Patients were excluded from the study if any of the following conditions were present: degenerative visual disorders or other pre-existing processes that permanently limit the corrected distance visual acuity to >0.3 logMAR, glaucoma and/or IOP > 24 mm Hg, or any other pathology or condition that the investigator may consider to be a risk. All patients were adequately informed about the study and signed a consent form, following the tenets of the Declaration of Helsinki. The ethics committee of each participating centre approved the study.
Examination protocol
A complete preoperative ophthalmological examination was performed on all patients. After surgery, patients were evaluated at 1-2 days, 1 week (7 AE 2 days), and at 1 (30 AE 5 days), 3 (120 AE 10 days), 6 (180 AE 15 days) and 12 months (360 AE 15 days) after surgery. Binocular contrast sensitivity measurements (Functional Vision Analyzer, Stereo Optical, Chicago, USA) under photopic (85 cd/m 2 ) and mesopic conditions (3 cd/m 2 ) were done at 1 and 12 months after surgery. Furthermore, patients were asked at 1 and 6 months after surgery to evaluate subjectively their level of perception of glare and halo type (Fig. 1) , by scaling symptoms in size and intensity using a simulating computer software (Halo & Glare Simulator, Eyeland-Design, Vreden, Germany). The simulator uses a scale for intensity, size of the halo and the glare that goes from 0 (none) to 100 (extremely disturbing). An in-house questionnaire was used to ask patients, at 1 and 6 months postoperatively, PCO was evaluated by slit-lamp examination 3, 6 and 12 months postoperatively after mydriatic dilatation of the eye, and assessed according to the following grading (4 point) scale of intensity: no, mild, moderate or severe PCO. PCO requiring Nd:YAG was defined as clinically significant PCO adversely affecting the subject's visual acuity and requiring posterior capsulotomy.
TYPE OF HALO
T1
T2 T3 Figure 1 . Types of halo (T1, T2 and T3) defined by the simulator, Halo & Glare Simulator from Eyeland-Design, used in our study.
Surgery
All surgeries were performed by one of the four experienced surgeons (JLA, DB, HK, and BC) using a standard technique of sutureless microincision phacoemulsification and an incision size of ≤2.2 mm. Topical anaesthesia and mydriatic drops were instilled in all cases prior to the surgical procedure. The general surgical procedure included the following sequential steps: injection of viscoelastic into the anterior chamber, capsulorrhexis, hydrodissection, nucleus removal by phacoemulsification, irrigation/aspiration of cortical material and capsular polishing, IOL implantation using the specific injector for such purpose and viscoelastic removal. 
Statistical analysis
RESULTS
A total of 104 eyes of 52 patients with a mean age of 63.2 AE 7.7 years were enrolled, but three patients withdrew prematurely after surgery. The final numbers of patients/eyes were as follows: AT LISA group (34 eyes, 17 patients), AT LISA tri group (30 eyes, 15 patients) and ReSTOR group (34 eyes, 17 patients). Although there were statistically significant differences among groups preoperatively in axial length (P = 0.013), no significant differences were found in the power of the IOL implanted (P = 0.504). Table 1 shows the postoperative visual outcomes in all groups -six months after surgery. As shown, no differences were observed among groups for distance and near visual acuities (P ≥ 0.117). For intermediate vision the only statistically significant difference was detected for the distance-corrected intermediate visual acuity (DCIVA) at 90 cm between AT LISA 809 M and the AT LISAtri 839MP with better visual acuity for the AT LISAtri 839MP group (P = 0.04). No differences among groups were found for the rest of intermediate visual acuities (P ≥ 0.08).
Visual and refractive outcomes
Contrast sensitivity outcomes Figure 2 shows the mean binocular contrast sensitivity function under photopic and mesopic conditions. Contrast sensitivity values under photopic conditions were higher than the values found under mesopic conditions, for the spatial frequencies of 12 and 18 cycles/degree, but not the spatial frequencies of 1.5, 3 and -cycles/degree. This was true for all the IOLs tested. There were no statistically significant differences among the three IOL groups for either 1 or 6-month postoperative contrast sensitivity. The trifocal and bifocal groups showed similar patterns of contrast sensitivity at all spatial frequencies tested (P ≥ 0.053).
Patient satisfaction and spectacle independence
Patient satisfaction was very high. For far distance ≥88% of patients at 1 month postoperatively and ≥94% of patients at 6 months rated their satisfaction level as very good or good in the three groups. Similarly, for near distance, ≥ 88% of patients reported a good or very good level of satisfaction in the three groups at 1 and 6 months, postoperatively. For intermediate distance, patients in the AT LISA bifocal group were less satisfied with their vision (good or very good satisfaction 88.2%) compared to the two other groups (AT LISA tri 93.4%; ReSTOR group 94.2%). However, the difference was not statistically significant (P = 0.193). No statistically significant differences were found among groups in the satisfaction scores for far, intermediate and near vision at 1 (P ≥ 0.154) and 6 months after surgery (P ≥ 0.415). 1 month after surgery, 100% of patients said they would choose the same IOL again in the AT LISA and ReSTOR group, whereas this percentage was 80% in the AT LISA tri group. This suggested that the trifocal lens might require a longer adaptation period. To test this hypothesis, the same question was asked 6 months post-surgery, and in this case no significant differences among groups were detected: AT LISA 94.1%, AT LISA tri 93.3%, ReSTOR 100%, P = 0.754. No significant differences were found among groups in the spectacle dependence score for far, intermediate and near vision at 1 (P ≥ 0.180) and 6 months after surgery (P ≥ 0.296) (Fig. 3) . Figure 4 is a visual demonstration of the halo and glare simulation with the three IOL groups evaluated. The patients assess their night visual perception by scaling halo and glare symptoms in size and intensity using the simulating computer software Halo & Glare Simulator (eyeland-design network GmbH). The scales for sizes and intensities start from 0 (no halo) or glare to 100 (extremely disturbing). Three halo types can be identified by the patient ( Fig. 1; Table 2 ).
Photic phenomena outcomes
Halo types T1 and T2 were found at equal frequency for all IOLs at 1-month (35.3% for the AT Lisa group, 40-46.7% for the Lisa tri group and 41.2-47.1% for the ReSTOR group). Type 3 halos were less frequent (17.6% for the AT lisa group, 0.0% for the Lisa tri group and 5.09% for the ReSTOR group). At 6 months, the ratio of halo types varied and the halo size varied from 35.7 to 51.5 at 1 month and from 38.4 to 54.5 at 6 months. However, halo size and intensity at 1 and 6 months after surgery showed no significant differences (P ≥ 0.256). Likewise, no significant differences in the distribution of halos were found either among groups (P ≥ 0.152). The differences between groups were not statistically significant under simulator conditions at 1 and 6 months ( Table 2) . Concerning glare simulation, no significant differences among groups in size and intensity were found during the follow-up (P ≥ 0.710) ( Table 2 ).
Posterior capsular opacification
Posterior capsular opacification (PCO) requiring a Nd:YAG capsulotomy was not observed in the AT LISA tri group during the course of this study. In contrast, PCO requiring capsulotomy was observed in the ReSTOR group and, to a lesser and later extent, in the AT LISA group. One month postoperatively one eye (2.9%) of the ReSTOR group underwent capsulotomy. Six months postoperatively, three (8.8%) additional posterior capsulotomies were performed in the ReSTOR group. In the final follow-up 12 months postoperatively, two (5.9%) further posterior capsulotomies were performed in the ReSTOR group and three eyes (8.8%) requiring posterior capsulotomies were observed in the AT LISA group. One of these PCO cases caused a significant loss in BCVA at 6 months; however, at 12 months there were no visually significant PCOs. A significantly higher number of eyes without PCO (93.3%) for AT LISA tri group was found compared to the AT LISA group (61.8%) at 3 months postsurgery (P = 0.003) ( Table 3) .
DISCUSSION
In this multi-centre tripartite randomized trial, three different IOLs were evaluated under identical conditions and found capable of providing effective visual restoration of distance and near visual function, as has been demonstrated individually for each type of IOL in previous studies. 7 ReSTOR and AT LISA IOLs show no significant differences in photopic and mesopic contrast sensitivity, with both IOLs providing contrast sensitivity within the normal range in photopic conditions. 11 Alió et al., 12 also found no significant differences in contrast sensitivity among ReSTOR and bifocal AT LISA IOLs in a comparative series, but the contrast sensitivity values for low spatial frequencies were significantly lower with these diffractive-refractive IOLs when compared to a AT LISA 809M monofocal IOL. Other studies 13, 14 reported no statistical differences in contrast sensitivity between AT LISA tri and AT LISA IOLs. Our findings in this publication are the same, therefore we confirm that the third focus of this model of trifocal IOL does not decrease the contrast sensitivity.
The size and intensity of glare and halos were also characterized in our study with a simulator in order to provide a quantitative analysis of this type of potentially disturbing perception. No statistically significant differences among groups were found in halo and glare size and intensity at 1 and 6 months after surgery, with no significant differences either in the distribution of halo types (T1, T2 and T3; Fig. 1 ). Vega et al.,
2 demonstrated in an optical bench study that diffractive multifocal IOLs show, at their foci, secondary out-of-focus images, from which halos originate and whose characteristics depend on the lens design and pupil size. However, the perception of these halos by the three IOL groups evaluated was not significantly different. The neural processing of the visual disturbances as well as neuroadaptation may play a crucial role in patient perception. Law et al., 15 reported a reduction in the perception of halos over time in eyes implanted with AT LISA trifocal IOL, decreasing from 80% at 1 month to 40% at 6 months after surgery. Kretz et al., 16 reported on halo size using a simulator and found values for size and intensity similar to those reported here. However, measurements were only taken at one time point during the 3 month followup period. The study reported here is the first analysis using a simulator over a 6-month period.
In our study, the postoperative satisfaction score did not differ significantly for the three IOLs evaluated. Although some differences among groups were detected in intermediate vision, this does not appear to be reflected in patient satisfaction. The overall effect of restoring vision with spectacle independence could mean that the patient is highly subjective in grading his/her level of satisfaction concerning vision at specific distances. Indeed, we found no statistically significant differences among groups concerning spectacle independence for far, intermediate and near vision. Gil et al., 17 detected statistically and clinically significant differences in CNVA and UNVA measured at 33 cm between different high and low add diffractive IOLs, but the overall satisfaction and quality of life scores were not significantly different. Cillino et al., 17 compared the visual outcomes, reading performance and quality of life (QoL) of patients bilaterally implanted with one of the three different diffractive multifocal IOLs (ReSTOR SN6AD3, ReSTOR SN6AD1 and Tecnis ZMA00), and were unable to find significant differences in 9 over 13 scales of the quality of life questionnaire NEI RQL-42. In our study, 100% of patients said they would choose the same IOL again in the AT LISA and ReSTOR group at 1 month after surgery, whereas this percentage was 80% in the AT LISA tri group. However, at 6 months post-surgery, no significant differences among groups were detected in the percentage of patients that would choose the same IOL again (AT LISA 94.1%, AT LISA tri 93.3%, ReSTOR 100%, P = 0.754). This would suggest that there is a longer period of neuroadaptation for the trifocal lens 18 ; however, longer term satisfaction reaches the same levels as for the other IOL groups.
Visual outcomes can be influenced by the development of posterior capsular opacification (PCO) during the follow-up that can lead to distortion and loss of corrected visual acuity. Non-clinically significant PCO can be defined by the intensity of visual acuity disturbances and range from none to moderate. However, PCO requiring Nd:YAG capsulotomy is clinically significant and adversely affects visual acuity. During the 3, 6 and 12-month follow-ups in our series the ReSTOR group had a total of 6 (17.6%) patients with PCO requiring Nd:YAG capsulotomy and the bifocal AT LISA group had three patients (8.8%) at the 12 month follow-up only. These values are comparable to those reported by other authors in previous studies. 14, 19, 20 A recent retrospective study 21 analysed 5130 eyes, and 1743 with the AT Lisa 839 IOL. They reported that the time to Nd:YAG capsulotomy was significantly longer for the AT Lisa IOL than for the FineVision group (3387 eyes). They found that 9 months postoperatively, the Nd:YAG capsulotomy rate increased more in the AT Lisa group. It should be noted that, in this study, no PCO requiring Nd:YAG capsulotomy was necessary for the AT LISAtri group 12 months post-surgery. The design of the AT LISA tri includes an anti-PCO posterior profile that reinforces the effect of the square edges in preventing PCO formation and appears to be successful, at least in this 12-month follow-up study.
In conclusion, the bifocal diffractive-refractive, trifocal diffractive-refractive and apodized IOLs evaluated provide, during a 12-month follow-up, high levels of patient satisfaction and spectacle independence with comparable levels of photic phenomena. The addition of an intermediate focus the trifocal AT LISA tri IOL does not reduce contrast sensitivity or general patient satisfaction, and is not associated with increased levels of postoperative visual disturbances. Quality of life criteria are sustained with >90% patient satisfaction at 12 months post-surgery. The level of visual disturbances, including photic phenomena, after cataract surgery with implantation of a diffractive-refractive trifocal IOL is not significantly different to data obtained with patients implanted with diffractive-refractive bifocal or apodized IOLs. A large majority of patients did not find these disturbances bothersome. Diffractive-refractive or apodized-diffractive bifocal or diffractive-refractive trifocal IOLs provide effective restoration of visual function, with equivalent levels of contrast sensitivity. High and similar levels of patient satisfaction are achieved after cataract surgery with implantation of bifocal and trifocal diffractive-refractive, and apodized IOLs. The addition of an intermediate focus (AT LISA tri group) results in a longer period of adaptation. However, patients implanted with the trifocal had high 6-month patient satisfaction and quality of life scores.
